Yan Feng, Michael Fan, Nathan Slotnick, Jie Su, Pin Huang, Ji Liu, Wei He. "A first-in-class KIF11 degrader antibody conjugate (DAC) as a potential therapy targeting a broad spectrum of cancers.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3092